![Mei-Chang Kuo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mei-Chang Kuo
Fondateur chez
ipharma Labs, Inc.
Profil
Mei-Chang Kuo is the founder of ipharma Labs, Inc., founded in 2016, and holds the title Head-Drug Development.
Dr. Kuo is also the founder of Aerorx Therapeutics, Inc...
Former jobs include Director-Protein Chemistry at ImmuLogic Pharmaceutical Corp., Senior Director at Nektar Therapeutics, and Senior Vice President-Pharmaceutics at Aerami Therapeutics, Inc. Education includes a doctorate from the University of Wisconsin.
Postes actifs de Mei-Chang Kuo
| Sociétés | Poste | Début |
|---|---|---|
ipharma Labs, Inc.
 ipharma Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an inhalation development contract research organization | Fondateur | 01/01/2016 |
Anciens postes connus de Mei-Chang Kuo
| Sociétés | Poste | Fin |
|---|---|---|
ImmuLogic Pharmaceutical Corp.
 ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
| NEKTAR THERAPEUTICS | Directeur/Membre du Conseil | - |
Aerami Therapeutics, Inc.
 Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled insulin products to treat diabetes patients | Corporate Officer/Principal | - |
Formation de Mei-Chang Kuo
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
4
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
ImmuLogic Pharmaceutical Corp.
ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Nektar Therapeutics
 Nektar Therapeutics Pharmaceuticals: MajorHealth Technology Discovers and develops medicines in areas of high unmet medical need | Health Technology |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled insulin products to treat diabetes patients | Health Technology |
ipharma Labs, Inc.
ipharma Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an inhalation development contract research organization | Commercial Services |
